This one-day meeting provides institutional, strategic and venture investors with unique insight into financing opportunities for cell and gene therapy-based treatment and tools. With significant technological advances and a number of recently approved products, the sector is poised for ever-increasing investor and analyst interest.
ARM’s Annual EU Advanced Therapies Investor Day is the only European financing event organized specifically for the sector – providing institutional, strategic and venture investors a unique opportunity to gain insight into the top advanced therapies companies.
30 Euston Square,
London NW1 2FB, UK